Offsets |
Nov. 13, 2025
USD ($)
shares
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Trevi Therapeutics, Inc. |
| Form or Filing Type | S-3 |
| File Number | 333-273030 |
| Initial Filing Date | Jun. 29, 2023 |
| Fee Offset Claimed | $ 2,243.56 |
| Security Type Associated with Fee Offset Claimed | Unallocated (Universal) Shelf |
| Security Title Associated with Fee Offset Claimed | Unallocated (Universal Shelf) |
| Unsold Securities Associated with Fee Offset Claimed | shares | 0 |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 20,359,070.00 |
| Termination / Withdrawal Statement | All offerings of the unsold securities associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Trevi Therapeutics, Inc. |
| Form or Filing Type | S-3 |
| File Number | 333-273030 |
| Filing Date | Jun. 29, 2023 |
| Fee Paid with Fee Offset Source | $ 2,243.56 |
| Offset Note | Pursuant to Rule 457(p) under the Securities Act, the registration fee applicable to the $200,000,000 of securities of the registrant being registered hereby in the amount of $27,620.00 is offset by $2,243.56, which represents the registration fee previously paid with respect to $20,359,070 of unsold securities under the registrant's Registration Statement on Form S-3 (File No. 333-273030) that was filed with the Securities and Exchange Commission (the "SEC") on June 29, 2023, as amended by Amendment No. 1 thereto that was filed with the SEC on August 11, 2023, which was declared effective by the SEC on August 15, 2023, resulting in a net registration fee due of $25,376.44. All offerings of the unsold securities associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated. |